USD 98.65
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 126.46 Billion EUR | 1.51% |
2022 | 124.58 Billion EUR | 3.61% |
2021 | 120.24 Billion EUR | 4.99% |
2020 | 114.52 Billion EUR | 1.59% |
2019 | 112.73 Billion EUR | 1.19% |
2018 | 111.4 Billion EUR | 11.6% |
2017 | 99.82 Billion EUR | -4.63% |
2016 | 104.67 Billion EUR | 2.3% |
2015 | 102.32 Billion EUR | 5.06% |
2014 | 97.39 Billion EUR | 1.38% |
2013 | 96.06 Billion EUR | -4.32% |
2012 | 100.4 Billion EUR | 0.24% |
2011 | 100.16 Billion EUR | 17.48% |
2010 | 85.26 Billion EUR | 6.51% |
2009 | 80.04 Billion EUR | 11.2% |
2008 | 71.98 Billion EUR | -0.06% |
2007 | 72.02 Billion EUR | -7.38% |
2006 | 77.76 Billion EUR | -10.2% |
2005 | 86.59 Billion EUR | 12.9% |
2004 | 76.69 Billion EUR | 688.13% |
2003 | 9.73 Billion EUR | 2.79% |
2002 | 9.46 Billion EUR | -5.01% |
2001 | 9.96 Billion EUR | 27.05% |
2000 | 7.84 Billion EUR | 15.18% |
1999 | 6.81 Billion EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 129.75 Billion EUR | 0.0% |
2024 Q1 | - EUR | -100.0% |
2023 Q3 | - EUR | -100.0% |
2023 Q1 | - EUR | -100.0% |
2023 Q2 | 125.35 Billion EUR | 0.0% |
2023 Q4 | 126.46 Billion EUR | 0.0% |
2023 FY | 126.46 Billion EUR | 1.51% |
2022 Q4 | 124.58 Billion EUR | 0.0% |
2022 Q1 | - EUR | -100.0% |
2022 FY | 124.58 Billion EUR | 3.61% |
2022 Q3 | - EUR | -100.0% |
2022 Q2 | 121.82 Billion EUR | 0.0% |
2021 Q1 | - EUR | -100.0% |
2021 Q4 | 120.24 Billion EUR | 0.0% |
2021 Q2 | 112.32 Billion EUR | 0.0% |
2021 Q3 | - EUR | -100.0% |
2021 FY | 120.24 Billion EUR | 4.99% |
2020 Q1 | - EUR | -100.0% |
2020 Q4 | 114.52 Billion EUR | 0.0% |
2020 Q2 | 115.81 Billion EUR | 0.0% |
2020 FY | 114.52 Billion EUR | 1.59% |
2020 Q3 | - EUR | -100.0% |
2019 Q4 | 112.73 Billion EUR | 0.0% |
2019 Q3 | - EUR | -100.0% |
2019 Q2 | 110.54 Billion EUR | 0.0% |
2019 Q1 | - EUR | -100.0% |
2019 FY | 112.73 Billion EUR | 1.19% |
2018 Q3 | - EUR | -100.0% |
2018 Q1 | 111.66 Billion EUR | 11.86% |
2018 FY | 111.4 Billion EUR | 11.6% |
2018 Q4 | 111.4 Billion EUR | 0.0% |
2018 Q2 | 112.77 Billion EUR | 1.0% |
2017 FY | 99.82 Billion EUR | -4.63% |
2017 Q2 | 101.87 Billion EUR | 0.0% |
2017 Q3 | - EUR | -100.0% |
2017 Q4 | 99.82 Billion EUR | 0.0% |
2017 Q1 | - EUR | -100.0% |
2016 Q1 | - EUR | -100.0% |
2016 FY | 104.67 Billion EUR | 2.3% |
2016 Q4 | 104.67 Billion EUR | 0.0% |
2016 Q3 | - EUR | -100.0% |
2016 Q2 | 99.11 Billion EUR | 0.0% |
2015 Q1 | - EUR | -100.0% |
2015 FY | 102.32 Billion EUR | 5.06% |
2015 Q3 | - EUR | -100.0% |
2015 Q2 | 97.92 Billion EUR | 0.0% |
2015 Q4 | 102.32 Billion EUR | 0.0% |
2014 Q1 | - EUR | -100.0% |
2014 Q4 | 97.39 Billion EUR | 0.0% |
2014 Q2 | 90.72 Billion EUR | 0.0% |
2014 Q3 | - EUR | -100.0% |
2014 FY | 97.39 Billion EUR | 1.38% |
2013 Q3 | - EUR | -100.0% |
2013 Q4 | 96.06 Billion EUR | 0.0% |
2013 FY | 96.06 Billion EUR | -4.32% |
2013 Q1 | - EUR | -100.0% |
2013 Q2 | 96.98 Billion EUR | 0.0% |
2012 FY | 100.4 Billion EUR | 0.24% |
2012 Q4 | 100.4 Billion EUR | 0.0% |
2012 Q2 | 101.74 Billion EUR | 0.0% |
2011 Q4 | 100.16 Billion EUR | 0.0% |
2011 Q2 | 99.59 Billion EUR | 0.0% |
2011 FY | 100.16 Billion EUR | 17.48% |
2010 Q2 | 86.24 Billion EUR | 0.0% |
2010 Q4 | 85.26 Billion EUR | 0.0% |
2010 FY | 85.26 Billion EUR | 6.51% |
2009 Q4 | 80.04 Billion EUR | 0.0% |
2009 Q2 | 76.75 Billion EUR | 0.0% |
2009 FY | 80.04 Billion EUR | 11.2% |
2008 Q4 | 71.98 Billion EUR | 0.0% |
2008 FY | 71.98 Billion EUR | -0.06% |
2008 Q2 | 67.56 Billion EUR | 0.0% |
2007 Q4 | 72.02 Billion EUR | 0.0% |
2007 FY | 72.02 Billion EUR | -7.38% |
2007 Q2 | 75.06 Billion EUR | 0.0% |
2006 Q4 | 77.76 Billion EUR | 0.0% |
2006 Q2 | 81.58 Billion EUR | 0.0% |
2006 FY | 77.76 Billion EUR | -10.2% |
2005 Q4 | 86.59 Billion EUR | 0.0% |
2005 Q2 | 89.13 Billion EUR | 0.0% |
2005 FY | 86.59 Billion EUR | 12.9% |
2004 Q4 | 76.69 Billion EUR | 0.0% |
2004 FY | 76.69 Billion EUR | 688.13% |
2004 Q2 | 10.54 Billion EUR | 0.0% |
2003 Q2 | 8.81 Billion EUR | 0.0% |
2003 FY | 9.73 Billion EUR | 2.79% |
2003 Q4 | 9.73 Billion EUR | 0.0% |
2002 FY | 9.46 Billion EUR | -5.01% |
2002 Q4 | 9.46 Billion EUR | 0.0% |
2002 Q2 | 9.41 Billion EUR | 0.0% |
2001 FY | 9.96 Billion EUR | 27.05% |
2000 FY | 7.84 Billion EUR | 15.18% |
1999 FY | 6.81 Billion EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
AstraZeneca PLC | 100.97 Billion USD | -25.241% |
Bristol-Myers Squibb Company PFD CONV 2 | 95.15 Billion USD | -32.898% |
CSPC Pharmaceutical Group Limited | 6.52 Billion USD | -1838.439% |
Clarus Therapeutics Holdings, Inc. | 51.7 Million USD | -244473.374% |
Novartis AG | 99.94 Billion USD | -26.534% |
PT Kalbe Farma Tbk. | 1.75 Billion USD | -7090.594% |